DAY ONE BIOPHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan DAY ONE BIOPHARMACEUTICALS 401(K) PLAN
| Measure | Date | Value |
|---|
| 2023 : DAY ONE BIOPHARMACEUTICALS 401(K) PLAN 2023 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2023-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Expenses. Interest paid | 2023-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $6,624,802 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $205,899 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $198,067 |
| Expenses. Certain deemed distributions of participant loans | 2023-12-31 | $0 |
| Value of total corrective distributions | 2023-12-31 | $8,055 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $5,424,730 |
| Value of total assets at end of year | 2023-12-31 | $10,485,353 |
| Value of total assets at beginning of year | 2023-12-31 | $4,066,450 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $-223 |
| Total income from rents | 2023-12-31 | $0 |
| Total interest from all sources | 2023-12-31 | $6,786 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $178,748 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $178,748 |
| Assets. Real estate other than employer real property at end of year | 2023-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $2,000,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $2,568,736 |
| Participant contributions at end of year | 2023-12-31 | $132,221 |
| Participant contributions at beginning of year | 2023-12-31 | $93,123 |
| Participant contributions at end of year | 2023-12-31 | $0 |
| Participant contributions at beginning of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $1,528,973 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $0 |
| Other income not declared elsewhere | 2023-12-31 | $0 |
| Administrative expenses (other) incurred | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at end of year | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2023-12-31 | $0 |
| Total non interest bearing cash at end of year | 2023-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2023-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Income. Non cash contributions | 2023-12-31 | $0 |
| Value of net income/loss | 2023-12-31 | $6,418,903 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $10,485,353 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $4,066,450 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2023-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2023-12-31 | $0 |
| Investment advisory and management fees | 2023-12-31 | $203 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $9,397,703 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $3,908,596 |
| Value of interest in pooled separate accounts at end of year | 2023-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2023-12-31 | $0 |
| Interest on participant loans | 2023-12-31 | $6,760 |
| Income. Interest from loans (other than to participants) | 2023-12-31 | $0 |
| Interest earned on other investments | 2023-12-31 | $0 |
| Income. Interest from US Government securities | 2023-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2023-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2023-12-31 | $829,898 |
| Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $64,728 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-12-31 | $1,136 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2023-12-31 | $3 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2023-12-31 | $3 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-12-31 | $26 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2023-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-12-31 | $0 |
| Asset value of US Government securities at end of year | 2023-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2023-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $999,575 |
| Net investment gain/loss from pooled separate accounts | 2023-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2023-12-31 | $14,963 |
| Net gain/loss from 103.12 investment entities | 2023-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Assets. Invements in employer securities at end of year | 2023-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2023-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2023-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2023-12-31 | $0 |
| Contributions received in cash from employer | 2023-12-31 | $1,327,021 |
| Employer contributions (assets) at end of year | 2023-12-31 | $124,395 |
| Employer contributions (assets) at beginning of year | 2023-12-31 | $0 |
| Income. Dividends from preferred stock | 2023-12-31 | $0 |
| Income. Dividends from common stock | 2023-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $198,067 |
| Asset. Corporate debt instrument preferred debt at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2023-12-31 | $0 |
| Contract administrator fees | 2023-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2023-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2023-12-31 | $0 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Aggregate proceeds on sale of assets | 2023-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2023-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2023-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2023-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | MARCUM LLP |
| Accountancy firm EIN | 2023-12-31 | 111986323 |
| 2022 : DAY ONE BIOPHARMACEUTICALS 401(K) PLAN 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2022-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total transfer of assets to this plan | 2022-12-31 | $2,776,008 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Expenses. Interest paid | 2022-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $1,420,991 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $130,549 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $125,715 |
| Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $0 |
| Value of total corrective distributions | 2022-12-31 | $4,714 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $1,302,236 |
| Value of total assets at end of year | 2022-12-31 | $4,066,450 |
| Value of total assets at beginning of year | 2022-12-31 | $0 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $120 |
| Total income from rents | 2022-12-31 | $0 |
| Total interest from all sources | 2022-12-31 | $911 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $54,130 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $54,130 |
| Assets. Real estate other than employer real property at end of year | 2022-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2022-12-31 | $0 |
| Administrative expenses professional fees incurred | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $2,000,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | Yes |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $453,321 |
| Participant contributions at end of year | 2022-12-31 | $93,123 |
| Participant contributions at beginning of year | 2022-12-31 | $0 |
| Participant contributions at end of year | 2022-12-31 | $0 |
| Participant contributions at beginning of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $671,548 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $0 |
| Other income not declared elsewhere | 2022-12-31 | $0 |
| Administrative expenses (other) incurred | 2022-12-31 | $120 |
| Liabilities. Value of operating payables at end of year | 2022-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2022-12-31 | $0 |
| Total non interest bearing cash at end of year | 2022-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Income. Non cash contributions | 2022-12-31 | $0 |
| Value of net income/loss | 2022-12-31 | $1,290,442 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $4,066,450 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $0 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2022-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $0 |
| Investment advisory and management fees | 2022-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $3,908,596 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $0 |
| Value of interest in pooled separate accounts at end of year | 2022-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $0 |
| Interest on participant loans | 2022-12-31 | $911 |
| Income. Interest from loans (other than to participants) | 2022-12-31 | $0 |
| Interest earned on other investments | 2022-12-31 | $0 |
| Income. Interest from US Government securities | 2022-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2022-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $64,728 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $3 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2022-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-12-31 | $0 |
| Asset value of US Government securities at end of year | 2022-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2022-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $63,343 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $371 |
| Net gain/loss from 103.12 investment entities | 2022-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Assets. Invements in employer securities at end of year | 2022-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2022-12-31 | $0 |
| Assets. Value of employer real property at end of year | 2022-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2022-12-31 | $0 |
| Contributions received in cash from employer | 2022-12-31 | $177,367 |
| Employer contributions (assets) at end of year | 2022-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2022-12-31 | $0 |
| Income. Dividends from preferred stock | 2022-12-31 | $0 |
| Income. Dividends from common stock | 2022-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $125,715 |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $0 |
| Contract administrator fees | 2022-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-31 | Yes |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-12-31 | $0 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Aggregate proceeds on sale of assets | 2022-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at end of year | 2022-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2022-12-31 | $0 |
